An Acerbate Psychotics Symptoms, Social Support, Stressful Life Events, Medication Use Self-Efficacy Impact on Social Dysfunction: A Cross Sectional Self-Rated Study of Persons with Schizophrenia Patient and Misusing Methamphetamines
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 33093
An Acerbate Psychotics Symptoms, Social Support, Stressful Life Events, Medication Use Self-Efficacy Impact on Social Dysfunction: A Cross Sectional Self-Rated Study of Persons with Schizophrenia Patient and Misusing Methamphetamines

Authors: Ek-Uma Imkome, Jintana Yunibhand, Waraporn Chaiyawat

Abstract:

Background: Persons with schizophrenia patient and misusing methamphetamines suffering from social dysfunction that impact on their quality of life. Knowledge of factors related to social dysfunction will guide the effective intervention. Objectives: To determine the direct effect, indirect effect and total effect of an acerbate Psychotics’ Symptoms, Social Support, Stressful life events, Medication use self-efficacy impact on social dysfunction in Thai schizophrenic patient and methamphetamine misuse. Methods: Data were collected from schizophrenic and methamphetamine misuse patient by self report. A linear structural relationship was used to test the hypothesized path model. Results: The hypothesized model was found to fit the empirical data and explained 54% of the variance of the psychotic symptoms (X2 = 114.35, df = 92, p-value = 0.05, X2 /df = 1.24, GFI = 0.96, AGFI = 0.92, CFI = 1.00, NFI = 0.99, NNFI = 0.99, RMSEA = 0.02). The highest total effect on social dysfunction was psychotic symptoms (0.67, p<0.05). Medication use self-efficacy had a direct effect on psychotic symptoms (-0.25, p<0.01), and social support had direct effect on medication use self efficacy (0.36, p <0.01). Conclusions: Psychotic symptoms and stressful life events were the significance factors that influenced direct on social dysfunctioning. Therefore, interventions that are designed to manage these factors are crucial in order to enhance social functioning in this population.

Keywords: Psychotic symptoms, methamphetamine, schizophrenia, stressful life events, social dysfunction, social support, medication use self-efficacy.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1316023

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1027

References:


[1] Westermeyer J. Comorbid Schizophrenia and Substance Abuse: A Review of Epidemiology and Course. The American Journal on Addictions. 2006; 15: 345-355.
[2] Sadock BJ, Sadock VA. & Ruiz P. Kaplan and Sadock’s Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2015.
[3] Wanda K. Mohr. Psychiatric-Mental Health Nursing: Evidence-Based Concepts, Skills, and Practices. Lippincott Williams & Wilkins; 2013.
[4] Nuechterlein, K. H., & Dawson, M. E. A heuristic vulnerability-stress model of schizophrenic episodes. Schizophrenia Bulletin; 1984.
[5] Hair, J. F., Black, W. C., Babin, B. J., Anderson, R. E., and Ththam, R. L. Multivariate Data Analysis, 6th ed. Upper Saddle River, New Jersey: Prentice-Hall International; 2010.
[6] Jöreskog, K., and Sörbom, D. LISREL 8: User’s reference guide. Lincolnwood. IL:Scientific Software International; 2015.
[7] Varcarolis, Elizabeth M., and Halter, M.J. (2015). Foundatoin of Psychiatric Mental Health Nursing: A Clinical Approach. (7th ed.). St. Louis: Elsevier; 2015.
[8] Hooley, J. Expressed emotion and relapse of psychopathology. Annual Review of Clinical Psychology. 2007; 3, 329–352.
[9] Leclerc, C., Lesage, A.D., Ricard, N., Lecomte, T., & Cyr, M. (2000). Assessment of a new rehabilitative coping skills module for persons with schizophrenia. American Journal of Orthopsychiatry. 70; 380-388.
[10] Yanos, P.T. Proactive coping among persons diagnosed with severe mental illness: An exploratory study. Journal of Nervous and Mental Disease. 2001; 189: 121-123.
[11] Frese, F.J. Twelve aspects of coping for persons with schizophrenia. Innovations and Research. 1993; 2: 39-46.
[12] Mueser, K.T., Valentiner, D.P., & Agresta, J. Coping with negative symptoms of schizophrenia: Patients and family perspectives. Schizophrenia Bulletin. 1997; 23: 329-339.
[13] Brown GW, Birley JL. Crises and life changes and the onset of schizophrenia. J Health Soc Behav. 1968; 9(3):203–214.
[14] Yager J. A, & Ehmann, T. S. Untangling social function and social cognition: a review of concepts and measurement. Psychiatry. 2006; 69: 47-68.
[15] Lysaker, P.H., Bryson, G.J., Lancaster, R.S., Evans, J.D., & Bell, M.D. Insight in schizophrenia: Associations with executive function and coping style. Schizophrenia Research. 2003; 59: 41-47.
[16] Wilder-Willis, K.E., Shear, P.K., Steffen, J.J., & Borkin, J. The relationship between cognitive dysfunction and coping abilities in schizophrenia. Schizophrenia Research. 2002; 55, 259-267.